Viewing Study NCT02621905


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2026-03-01 @ 2:44 PM
Study NCT ID: NCT02621905
Status: COMPLETED
Last Update Posted: 2018-10-26
First Post: 2015-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg
Sponsor: Mayne Pharma International Pty Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neutropenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prophylaxis View
None Steady-State View
None Bioavailability View